HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jae Ho Kim Selected Research

Trp-Lys-Tyr-Met-Val-Met

11/2022Combination Therapy of Placenta-Derived Mesenchymal Stem Cells with WKYMVm Promotes Hepatic Function in a Rat Model with Hepatic Disease via Vascular Remodeling.
2/2021Formyl Peptide Receptor 2 Alleviates Hepatic Fibrosis in Liver Cirrhosis by Vascular Remodeling.
12/2020WKYMVm ameliorates acute lung injury via neutrophil antimicrobial peptide derived STAT1/IRF1 pathway.
1/2019Formyl Peptide Receptor 2 Activation Ameliorates Dermal Fibrosis and Inflammation in Bleomycin-Induced Scleroderma.
1/2019WKYMVm hexapeptide, a strong formyl peptide receptor 2 agonist, attenuates hyperoxia-induced lung injuries in newborn mice.
1/2016Biomedical therapy using synthetic WKYMVm hexapeptide.
10/2015Injectable PLGA microspheres encapsulating WKYMVM peptide for neovascularization.
7/2015Stimulation of cutaneous wound healing by an FPR2-specific peptide agonist WKYMVm.
3/2014WKYMVm-induced activation of formyl peptide receptor 2 stimulates ischemic neovasculogenesis by promoting homing of endothelial colony-forming cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jae Ho Kim Research Topics

Disease

67Neoplasms (Cancer)
04/2024 - 08/2002
18Ovarian Neoplasms (Ovarian Cancer)
03/2024 - 03/2008
13Ischemia
01/2023 - 11/2006
12Prostatic Neoplasms (Prostate Cancer)
12/2023 - 09/2002
11Neoplasm Metastasis (Metastasis)
03/2024 - 06/2011
11Inflammation (Inflammations)
01/2023 - 11/2002
8Wounds and Injuries (Trauma)
04/2023 - 07/2011
7Ovarian Epithelial Carcinoma
03/2024 - 01/2011
7Radiation Injuries (Radiation Sickness)
09/2014 - 02/2004
5Necrosis
07/2023 - 09/2003
5Myocardial Infarction
03/2021 - 11/2013
5Vascular Diseases (Vascular Disease)
02/2019 - 11/2008
5Carcinoma (Carcinomatosis)
07/2014 - 08/2002
4Breast Neoplasms (Breast Cancer)
04/2024 - 04/2012
4Vascular Remodeling
02/2023 - 01/2008
4Cardiotoxicity
10/2022 - 10/2017
4Fibrosis (Cirrhosis)
02/2021 - 11/2008
4Lung Neoplasms (Lung Cancer)
01/2018 - 11/2006
4Carcinogenesis
01/2018 - 02/2012
4Adenocarcinoma of Lung
11/2012 - 11/2010
3Stroke (Strokes)
11/2023 - 08/2022
3Peripheral Arterial Disease
09/2020 - 10/2017
3Acute Kidney Injury (Acute Renal Failure)
03/2019 - 09/2003
3Rheumatoid Arthritis
02/2018 - 01/2010
3Cardiovascular Diseases (Cardiovascular Disease)
07/2016 - 01/2008
3Brain Neoplasms (Brain Tumor)
05/2013 - 05/2008
3Glioma (Gliomas)
01/2012 - 12/2003
3Adenocarcinoma
01/2011 - 09/2007
3Optic Nerve Diseases (Optic Neuropathy)
04/2007 - 05/2002
2Triple Negative Breast Neoplasms
04/2024 - 12/2022
2Infarction (Infarctions)
11/2023 - 03/2021
2Hemorrhage
11/2023 - 08/2020
2Chronic Limb-Threatening Ischemia
07/2023 - 01/2021
2Hyperplasia
02/2023 - 12/2021
2Parkinson Disease (Parkinson's Disease)
01/2023 - 10/2010
2Melanoma (Melanoma, Malignant)
06/2022 - 11/2021
2Obesity
01/2022 - 06/2014
2Infections
01/2022 - 04/2016
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018 - 09/2007

Drug/Important Bio-Agent (IBA)

13lysophosphatidic acidIBA
03/2016 - 05/2003
10Therapeutic UsesIBA
01/2023 - 01/2012
10Proteins (Proteins, Gene)FDA Link
01/2023 - 04/2010
9Trp-Lys-Tyr-Met-Val-MetIBA
11/2022 - 03/2014
9CytokinesIBA
01/2019 - 11/2005
9Conditioned Culture MediaIBA
11/2012 - 03/2008
8Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
01/2022 - 03/2014
7PeriostinIBA
04/2016 - 01/2011
6Doxorubicin (Adriamycin)FDA LinkGeneric
06/2022 - 01/2016
6Small Interfering RNA (siRNA)IBA
06/2021 - 04/2010
5HydrogelsIBA
04/2024 - 06/2021
5Extracellular Matrix ProteinsIBA
09/2014 - 01/2011
5Interleukin-6 (Interleukin 6)IBA
08/2013 - 11/2005
5sodium-iodide symporter (sodium iodide symporter)IBA
01/2013 - 04/2007
5Cytosine DeaminaseIBA
01/2012 - 09/2002
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2011 - 08/2002
5Ramipril (Altace)FDA LinkGeneric
02/2011 - 02/2004
4CollagenIBA
02/2023 - 11/2008
4Glucose (Dextrose)FDA LinkGeneric
01/2022 - 07/2016
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 04/2010
4Lysophosphatidic Acid ReceptorsIBA
01/2011 - 05/2008
43- (4- (4- ((1- (2- chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acidIBA
11/2010 - 03/2008
4Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
02/2010 - 02/2004
4Thymidine KinaseIBA
09/2007 - 09/2002
3Phosphotransferases (Kinase)IBA
08/2022 - 11/2006
3LipidsIBA
01/2022 - 01/2011
3G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2019 - 06/2012
3Paclitaxel (Taxol)FDA LinkGeneric
11/2017 - 06/2010
3Peptides (Polypeptides)IBA
10/2017 - 07/2015
3Cisplatin (Platino)FDA LinkGeneric
01/2016 - 09/2003
3Oncostatin MIBA
08/2013 - 11/2005
3Biomarkers (Surrogate Marker)IBA
11/2012 - 01/2011
3AntioxidantsIBA
04/2010 - 09/2003
2Biocompatible Materials (Biomaterials)IBA
04/2024 - 01/2023
2DisulfidesIBA
04/2024 - 11/2016
2Prostate-Specific Antigen (Semenogelase)IBA
12/2023 - 06/2014
2SilkFDA Link
02/2023 - 12/2021
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2022 - 11/2006
2SodiumIBA
03/2021 - 05/2003
2Protein Isoforms (Isoforms)IBA
01/2021 - 11/2012
2ATP-Binding Cassette Transporters (ABC Transporters)IBA
12/2020 - 08/2016
2MicellesIBA
11/2020 - 11/2016
2erucylphosphocholineIBA
01/2020 - 11/2013
2Tamsulosin (Flomax)FDA LinkGeneric
01/2019 - 01/2014
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2019 - 01/2013
2Polyglactin 910IBA
12/2017 - 01/2016

Therapy/Procedure

31Therapeutics
04/2024 - 11/2002
22Radiotherapy
01/2023 - 08/2002
12Injections
04/2024 - 06/2010
10Drug Therapy (Chemotherapy)
04/2024 - 06/2004
9Transplantation
07/2023 - 11/2010
7Heterologous Transplantation (Xenotransplantation)
11/2021 - 11/2010
3Stents
11/2023 - 01/2016
3Intramuscular Injections
07/2023 - 03/2014
3Aftercare (After-Treatment)
01/2019 - 10/2007
3Microspheres (Microsphere)
12/2017 - 10/2015
2Photothermal Therapy
04/2024 - 11/2021
2Electrodes (Electrode)
10/2022 - 11/2020
2Surgical Amputation (Amputations)
06/2022 - 01/2021
2Limb Salvage
01/2021 - 09/2020
2Brachytherapy
09/2018 - 06/2007